Literature DB >> 22502674

Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma.

Zhong-Zheng Zhu1, Dong Wang, Wen-Ming Cong, Hongmei Jiang, Yue Yu, Bing-Ji Wen, Hui Dong, Xiao Zhang, Shu-Fang Liu, Ai-Zhong Wang, Guanshan Zhu, Lifang Hou.   

Abstract

BACKGROUND: Males have a higher prevalence of hepatocellular carcinoma (HCC) than females in general, but the reasons for the sex disparity are still obscure. DNA copy number alteration (CNA) is a major feature of solid tumors including HCC, but whether CNA plays a role in sex-related differences in HCC development has never been evaluated.
METHODS: High-resolution array comparative genomic hybridization (CGH) was used to examine 17 female and 46 male HCC patients with chronic hepatitis B virus (HBV) infection in Shanghai, China. Two-tailed Fisher's exact or chi2 tests was used to compare CNAs between females and males.
RESULTS: The overall frequencies and patterns of CNAs in female and male cases were similar. However, female HCC tumors presented more copy number gains compared to those in males on 1q21.3-q22 (76.5% vs. 37.0%, P = 0.009), 11q11 (35.3% vs. 0.0%, P = 0.0002) and 19q13.31-q13.32 (23.5% vs. 0.0%, P = 0.004), and loss on 16p11.2 (35.3% vs. 6.5%, P = 0.009). Relative to females, male cases had greater copy number loss on 11q11 (63.0% vs. 17.6%, P = 0.002). Further analyses showed that 11q11 gain correlated with 19q13.31-q13.32 gain (P = 0.042), 11q11 loss (P = 0.011) and 16p11.2 loss (P = 0.033), while 1q21.3-q22 gain correlated with 19q13.31-q13.32 gain (P = 0.046).
CONCLUSIONS: These findings suggest that CNAs may play a role in sex-related differences in HBV-associated HCC development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502674     DOI: 10.7314/apjcp.2012.13.1.225

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.

Authors:  Weixiang Chen; Jun Ding; Long Jiang; Zebing Liu; Xiaoyan Zhou; Daren Shi
Journal:  Funct Integr Genomics       Date:  2016-11-28       Impact factor: 3.410

2.  Depletion of UBA protein 2-like protein inhibits growth and induces apoptosis of human colorectal carcinoma cells.

Authors:  Rui Chai; Xiaojun Yu; Shiliang Tu; Bo'an Zheng
Journal:  Tumour Biol       Date:  2016-07-25

Review 3.  Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wei-Cheng Liu; Quan-Yan Liu
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience.

Authors:  Masatsugu Endo; Hiroki Nishikawa; Ryuichi Kita; Toru Kimura; Yoshiaki Ohara; Azusa Sakamoto; Sumio Saito; Norihiro Nishijima; Akihiro Nasu; Hideyuki Komekado; Yukio Osaki
Journal:  Mol Clin Oncol       Date:  2016-01-28

5.  Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro.

Authors:  Bing Zhao; Gang Zong; Yongsheng Xie; Jia Li; Hongliang Wang; Erbao Bian
Journal:  Int J Mol Med       Date:  2015-08-24       Impact factor: 4.101

6.  Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term population-based cohort study.

Authors:  Chun-Hsiang Wang; Ruey-Chang Lin; Hua-Yin Hsu; Yuan-Tsung Tseng
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

Review 7.  Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Maurizio Montella; Giovanni D'Arena; Anna Crispo; Mario Capunzo; Flavia Nocerino; Maria Grimaldi; Antonio Barbieri; Anna Maria D'Ursi; Mario Felice Tecce; Alfonso Amore; Massimiliano Galdiero; Gennaro Ciliberto; Aldo Giudice
Journal:  Int J Endocrinol       Date:  2015-09-27       Impact factor: 3.257

8.  UBA2 promotes proliferation of colorectal cancer.

Authors:  Ping He; Xun Sun; Hong-Jing Cheng; Ya-Bin Zou; Quan Wang; Chang-Li Zhou; Wan-Qi Liu; Yue-Ming Hao; Xiang-Wei Meng
Journal:  Mol Med Rep       Date:  2018-10-30       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.